These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8275706)

  • 1. Localization of the human alpha-fodrin gene (SPTAN1) to 9q33-->q34 by fluorescence in situ hybridization.
    Upender M; Gallagher PG; Moon RT; Ward DC; Forget BG
    Cytogenet Cell Genet; 1994; 66(1):39-41. PubMed ID: 8275706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation.
    Sessarego M; Fugazza G; Canepa L; Bacigalupo A; Bruzzone R; Patrone F
    Leuk Res; 1995 Dec; 19(12):921-5. PubMed ID: 8632661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukemia with a rare variant Philadelphia translocation: t(9;10;22)(q34;q22;q11).
    Emberger W; Behmel A; Tschernigg M; Seewann HL; Petek E; Kroisel PM; Wagner K
    Cancer Genet Cytogenet; 2001 Aug; 129(1):76-9. PubMed ID: 11520571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 6. Philadelphia chromosome of a constitutional der(22)t(Y;22)(q11.2;p11) with a variant t(1;9;22)(p36;q34;q11) in a case of chronic myelogenous leukemia.
    Buijs A; Terhal PA; Thunnissen PL
    Cancer Genet Cytogenet; 2006 Jul; 168(1):80-2. PubMed ID: 16772126
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial diagnosis of chronic myelogenous leukemia based on quantification of M-BCR status using droplet digital PCR.
    Lund HL; Hughesman CB; McNeil K; Clemens S; Hocken K; Pettersson R; Karsan A; Foster LJ; Haynes C
    Anal Bioanal Chem; 2016 Feb; 408(4):1079-94. PubMed ID: 26631023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of a portion of the chromosomal gene and cDNA for human beta-fodrin, the nonerythroid form of beta-spectrin.
    Chang JG; Scarpa A; Eddy RL; Byers MG; Harris AS; Morrow JS; Watkins P; Shows TB; Forget BG
    Genomics; 1993 Aug; 17(2):287-93. PubMed ID: 8406479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1.
    Wu HK; Heng HH; Siderovski DP; Dong WF; Okuno Y; Shi XM; Tsui LC; Minden MD
    Oncogene; 1996 Mar; 12(6):1205-12. PubMed ID: 8649822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13).
    Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D
    Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
    Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different patterns of chromosome and molecular breakage in classic Ph1 chronic myelogenous leukemia (CML) and variant Ph1 CML.
    Koduru P; Goh JC; Allen SL; Karp L; Jasti H; DeMarco LC; Lichtman SM
    Hematol Pathol; 1991; 5(2):57-66. PubMed ID: 1894583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location of the BCR-ABL fusion gene on the 9q34 band in two cases of Ph-positive chronic myeloid leukemia.
    Aurich J; Dastugue N; Duchayne E; Schlaifer D; Rigal-Huguet F; Caballin MR
    Genes Chromosomes Cancer; 1997 Oct; 20(2):148-54. PubMed ID: 9331565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
    Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cDNA cloning, sequencing and chromosome mapping of a non-erythroid spectrin, human alpha-fodrin.
    McMahon AP; Giebelhaus DH; Champion JE; Bailes JA; Lacey S; Carritt B; Henchman SK; Moon RT
    Differentiation; 1987; 34(1):68-78. PubMed ID: 3038643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous occurrence of t(9;22)(q34;q11.2) and t(16;16)(p13;q22) in a patient with chronic myeloid leukemia in blastic phase.
    Zámecníkova A; Al Bahar S; Ramesh P
    Cancer Genet Cytogenet; 2008 Jun; 183(2):109-13. PubMed ID: 18503829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(9;22)(q34;q11.2) is a recurrent constitutional non-Robertsonian translocation and a rare cytogenetic mimic of chronic myeloid leukemia.
    Czuchlewski DR; Farzanmehr H; Robinett S; Haines S; Reichard KK
    Cancer Genet; 2011 Oct; 204(10):572-6. PubMed ID: 22137489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.